Skip to content

Clinical trials

Phase 4 Hepatitis C, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 4 Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20026
200311
20048
200516
200614
200714
20086
20096
20101
201111
20124
20136
20143
20157
20169
20178
20184
20193
20203
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Unknown status21
Terminated16
Withdrawn5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche28
Merck Sharp & Dohme LLC7
Kaohsiung Medical University Chung-Ho Memorial Hospital6
National Taiwan University Hospital6
Kirby Institute5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Center For Hepatitis C, Atlanta, GA2
Duke University2
Federal University of São Paulo2
Göteborg University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic144
Hepatitis C34
HIV Infections7
Carcinoma, Hepatocellular4
Coinfection4
Fibrosis4
Hepatitis4
Insulin Resistance4
Kidney Failure, Chronic4
Opioid-Related Disorders4

Trials

Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.